<DOC>
	<DOCNO>NCT01252810</DOCNO>
	<brief_summary>To evaluate cardio-renal overall safety profile GE 145 320 mg I/ml Injection compare iopamidol 370 mg I/mL . The study focus elderly subject either chronic renal insufficiency , diabetes mellitus ( DM ) require drug therapy , congestive heart failure ( CHF ) NYHA Class III great , refer coronary catheterization procedure without PCI .</brief_summary>
	<brief_title>Safety Study GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL Elderly Subjects Undergoing Coronary Procedure</brief_title>
	<detailed_description />
	<criteria>Males females 65 year age cardiovascular disease refer coronary catheterization procedure without PCI . The subject least one follow comorbidities : 1 ) Chronic renal insufficiency , ( eGFR &lt; 60 15 mL/min/1.73 m2 accord MDRD equation ) measure within 2 week screen visit ; 2 ) DM diagnose great 6 month prior study entry require either insulin antihyperglycemic drug therapy ; 3 ) CHF ( NYHA ) class III great measure within 2 week enrollment screen visit . The subject know allergy either iodine ICM . The subject severe renal insufficiency ( eGFR &lt; 15 mL/min/1.73 m2 accord MDRD equation ) dialysis . The subject acute coronary syndrome require emergency coronary angiography and/or intervention . The subject willing unable discontinue metformin ( e.g. , Glucophage ) time study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>CATH Catheterization</keyword>
	<keyword>CI-AKI Contrast-induced acute kidney injury</keyword>
	<keyword>DM Diabetes mellitus</keyword>
	<keyword>eGFR Estimated glomerular filtration rate</keyword>
	<keyword>MDRD Modification Diet Renal Disease</keyword>
	<keyword>NYHA New York Heart Association</keyword>
	<keyword>PCI Percutaneous coronary intervention</keyword>
	<keyword>SCr Serum creatinine</keyword>
</DOC>